openPR Logo
Press release

Cholesterol Medicine Market to Reflect Steady Growth During 2017-2027

02-22-2018 10:44 AM CET | Health & Medicine

Press release from: Future Market Insights

/ PR Agency: Future Market Insights
Cholesterol Medicine Market to Reflect Steady Growth During

Cholesterol is white, waxy, fat deposit in the blood stream that is manufactured in the liver and released into the blood. A small amount of cholesterol is needed by the body to work efficiently. The body produces all the cholesterol needed for the production of hormones, vitamin D and the all the substance required for food digestion. The main external source of cholesterol is found in the food we eat. Sufficient amount of cholesterol is vital for body function, but increased level of cholesterol may cause serious health problems. About 75% of cholesterol are produced by liver and other cells of the body. Cholesterol travels through blood stream in small packages known as the lipoprotein. Two types of lipoprotein are present to carry cholesterol known as low-density lipoproteins (LDL) and high-density lipoproteins (HDL).Healthy level both lipoprotein are important for proper functioning of the body.

Low-density lipoproteins (LDL) are known as bad cholesterol as they get deposit in the arteries, causing chest pain, heart attack, stroke and other kidney and circulation problems. High-density lipoproteins (HDL) are known as good cholesterol as it carries cholesterol from all parts of the body to the liver and liver finally removes the cholesterol out of the body. The more the HDL level, the healthy you are, proper exercise and diet help to maintain good cholesterol level. Triglycerides, the third form of cholesterol that are present in high concentration in people who are diabetic or alcoholic, it increases the chances of cardiovascular diseases. Lifestyle changes such as reduction in dietary saturated fat and cholesterol, with proper exercise and weight control, would help in lowering cholesterol level. Excess weight trends to increase LDL level, so regular exercise is necessary for lowering LDL level and increasing low high –density lipoproteins.

The level of cholesterol increases with age, nearly 1 in every 2 women in America suffers from high cholesterol level. Hypercholesterolaemia (high cholesterol) is one of the major cause of death in the world, about 2.6 million death occur per year worldwide. According to world health organization, in the European Union five biggest countries - Germany, France, Italy, Spain and UK, 133 million people suffer from bad cholesterol. People with high level of blood cholesterol have the greater chance of developing heart diseases as plaque (made up of fat, calcium, cholesterol, and other substances found in the blood) gets deposit inside the coronary arteries.

Request to Sample Report - https://www.futuremarketinsights.com/reports/sample/rep-gb-2698

Nowadays, a number of cholesterol-lowering medicines are available in a market. Statins are mostly used as the standard therapy in the treatment of hypercholesterolemia. There are other alternative medicines and combined therapy available with both oral and injectable formulations in the market. According to the U.S. Centers for Disease Control and Prevention, in U.S about 73 million adults suffer from low-density lipoprotein. Cholesterol level varies by race, sex and ethnicity. Approximately 31 million Americans have total cholesterol level more than 240 mg/dL. Rising prevalence of cardiovascular diseases and new product launch are expected to drive the global cholesterol medicine market.

The global market for cholesterol medicine is segmented on basis of product type, distribution channel and geography:

Segment by Product Type

HMG-CoA Reductase Inhibitors (also called Statins)

Bile Acid Sequestrants

Fibrates

Niacin

Cholesterol Absorption Inhibitors

Omega-3 Fatty Acid

Combination Medicines

Segment by Route of Administration

Oral

Subcutaneous

Segment by Distribution Channel

Hospital Pharmacy

Drug Stores

Retail Pharmacy

E-commerce

Based on the Product type, the global cholesterol medicine market is segmented into HMG-CoA Reductase Inhibitors (Statins), bile acid sequestrants, fibrates, niacin, cholesterol absorption inhibitors, omega-3 fatty acid, combination medicines. Statins are mostly used as they are most effective drugs for lowering cholesterol, so statin is the leading segment, among product type in the global cholesterol medicine market and is expected to grow at the high rate during the forecast period. Based on the route of administration, the global cholesterol medicine market is segmented into oral, and subcutaneous. Based on the distribution channel, the global cholesterol medicine market is segmented into hospital pharmacy, drug stores, e-commerce and retail pharmacy

Request Report TOC @ https://www.futuremarketinsights.com/toc/rep-gb-2698

By regional presence, the global cholesterol medicine market is segmented into five broad regions viz. North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. North America is leading the cholesterol medicine market, as U.S. market is mature and highly penetrated. Europe market is also projected to experience high growth in the cholesterol medicine in the near future. Asia Pacific market is anticipated to grow at the fastest growth rate during the forecast period, owing to factors such as rising standard of living, lifestyle changes and focusing on healthcare expenditures.

Market: Key Players

Some of the major players in Cholesterol Medicines market are Abbott Laboratories, Merck & Co., Inc., Bristol-Myers Squibb Company, Pfizer Inc., AstraZeneca, Amgen Inc, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Regeneron Pharmaceuticals Inc. and others. Pharmaceutical companies are facing competition from increasing cheaper generic statins. Newer alternatives for medication using low generic drugs are entering the global market, along with expansion in the emerging markets, and greater focus on patient care and monitoring, have been the major strategies adopted by major players in the global allergic rhinitis market.

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website :www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cholesterol Medicine Market to Reflect Steady Growth During 2017-2027 here

News-ID: 953361 • Views:

More Releases from Future Market Insights

Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Million by 2032
Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Milli …
The lithium-ion battery separator is a critical component in lithium-ion batteries, responsible for preventing short circuits and ensuring safe and efficient battery performance. It acts as a physical barrier between the positive and negative electrodes, allowing lithium ions to pass through while blocking the flow of electrons. With advancements in separator technology, these separators play a key role in enhancing battery capacity, cycle life, and overall safety in various applications,
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolstered by a Robust 7.1% CAGR from 2022
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolst …
The Industrial Drums Market is experiencing a steady and promising trajectory, with an estimated value of US$ 12.5 billion in 2022, projected to escalate to US$ 17.6 billion by 2027 at a commendable Compound Annual Growth Rate (CAGR) of 7.1%. This growth is substantiated by a 6.6% CAGR in volume during 2022-27, as per Future Market Insights. Anticipated to expand 1.5 times within this period, the market presents alluring prospects for industry
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of the Metal Cans Industry, Catering to Health-conscious and Environmentally-aware Consumers
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of …
The metal cans market is predicted to grow at a CAGR of 5% over the forecast period, according to research by Future Market Insights. The industry's estimated value is expected to increase from US$ 56 Bn in 2023 to US$ 91.1 Bn by 2033. The market for metal cans has been driven by the heightened demand for the product in food and beverages industry. Metal cans helps prolong shelf-life of perishable
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 with a 4.8% CAGR
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 …
The folding intermediate bulk containers (IBCs) market is on a growth trajectory, with an estimated value of US$ 418 million in 2022, projected to reach US$ 528 million by 2027, showcasing a Compound Annual Growth Rate (CAGR) of 4.8%. Remarkably, the China folding IBCs market defied initial pandemic-related skepticism and is anticipated to grow by 6.9% year on year in 2022. Despite global challenges, China's folding IBCs market is poised to contribute

All 5 Releases


More Releases for Cholesterol

Cholesterol Screening/ Cholesterol Lab Testing Market Size, Share, Trends, Growt …
Market Analysis and Insights: Global Cholesterol Screening/ Cholesterol Lab Testing Market The research report studies the Cholesterol Screening/ Cholesterol Lab Testing market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its
Cholesterol Screening/ Cholesterol Lab Testing Services Market 2020 to Growth US …
New York, February 20, 2020: The Cholesterol Screening/ Cholesterol Lab Testing Services Market is expected to exceed more than US$ 17.57 Billion by 2021 at a CAGR of 8% in the given forecast period. Cholesterol is also one of the part of the substance system that is created by our body to keep our body healthy and well-functioning. Cholesterol plays a very important role in the individuals healthy heart. Cholesterol screening
Global Cholesterol Screening/ Cholesterol Lab Testing Services Market Size, Stat …
This report studies the global Cholesterol Screening/ Cholesterol Lab Testing Services market, analyzes and researches the Cholesterol Screening/ Cholesterol Lab Testing Services development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Laboratory Corporation of America Holdings Quest Diagnostics Eurofins Scientific Spectra Laboratories Unilabs Synlab International Bio-Reference Laboratories Clinical Reference Laboratory ACM Medical Laboratory Adicon Clinical Laboratory For more info, get a Sample PDF with TOC:
Learn Details of the Global Cholesterol Screening/ Cholesterol Lab Testing Servi …
Global Cholesterol Lab Testing Services Market: Overview The prevalence of sedentary lifestyles of people is expected to boost the demand for cholesterol lab testing services worldwide. Cholesterol is a waxy, fat-like substance present in the bloodstream, nerve fibers, and bodily organs. A person’s level of cholesterol is determined by factors such as heredity, consumption of food with high amounts of saturated fats (for example, animal products), and metabolic conditions such as
Cholesterol Screening/ Cholesterol Lab Testing Services Market 2016 - Industry R …
Global Cholesterol Lab Testing Services Market: Overview The prevalence of sedentary lifestyles of people is expected to boost the demand for cholesterol lab testing services worldwide. Cholesterol is a waxy, fat-like substance present in the bloodstream, nerve fibers, and bodily organs. A person’s level of cholesterol is determined by factors such as heredity, consumption of food with high amounts of saturated fats (for example, animal products), and metabolic conditions such as
Cholesterol Screening/ Cholesterol Lab Testing Services Market Research Report 2 …
Global Cholesterol Lab Testing Services Market: Overview The prevalence of sedentary lifestyles of people is expected to boost the demand for cholesterol lab testing services worldwide. Cholesterol is a waxy, fat-like substance present in the bloodstream, nerve fibers, and bodily organs. A person’s level of cholesterol is determined by factors such as heredity, consumption of food with high amounts of saturated fats (for example, animal products), and metabolic conditions such as